Beverly A Teicher Selected Research

Beverly A Teicher Research Topics

Disease

82	Neoplasms (Cancer) 01/2022 - 01/2002
11	Sarcoma (Soft Tissue Sarcoma) 11/2021 - 11/2008
10	Carcinoma (Carcinomatosis) 01/2021 - 08/2002
9	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2020 - 01/2002
9	Neoplasm Metastasis (Metastasis) 08/2014 - 11/2004
8	Breast Neoplasms (Breast Cancer) 07/2013 - 08/2002
7	Neuroblastoma 01/2020 - 02/2006
6	Renal Cell Carcinoma (Grawitz Tumor) 07/2013 - 10/2002
5	Multiple Myeloma 07/2015 - 05/2009
4	Leukemia 01/2021 - 05/2009
4	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 11/2008
4	Ewing Sarcoma (Sarcoma, Ewing) 01/2019 - 03/2011
4	Colonic Neoplasms (Colon Cancer) 10/2012 - 02/2006
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2012 - 04/2003
4	Ovarian Neoplasms (Ovarian Cancer) 09/2012 - 08/2002
3	Adenocarcinoma 12/2021 - 08/2011
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2009
3	Prostatic Neoplasms (Prostate Cancer) 10/2012 - 01/2007
3	Melanoma (Melanoma, Malignant) 10/2011 - 04/2008
2	Thyroid Neoplasms (Thyroid Cancer) 10/2012 - 09/2012
2	Glioma (Gliomas) 10/2012 - 08/2004
2	Hypoxia (Hypoxemia) 09/2012 - 01/2005
2	Lymphoma (Lymphomas) 10/2009 - 05/2009
1	Bites and Stings (Sting) 01/2020
1	Wilms Tumor (Wilm's Tumor) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2019
1	Alveolar Rhabdomyosarcoma 01/2019
1	Rhabdoid Tumor (Rhabdoid Tumors) 01/2019
1	Rhabdomyosarcoma 01/2019

Drug/Important Bio-Agent (IBA)

15	Pharmaceutical PreparationsIBA 12/2021 - 09/2003
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2004
8	Messenger RNA (mRNA)IBA 01/2022 - 03/2004
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2012 - 01/2002
7	Cytotoxins (Cytolysins)IBA 01/2022 - 03/2008
7	Transforming Growth Factor beta (TGF-beta)IBA 07/2008 - 10/2002
6	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 09/2012
6	Antineoplastic Agents (Antineoplastics)IBA 12/2021 - 08/2002
6	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021 - 11/2004
4	Transcription Factors (Transcription Factor)IBA 11/2021 - 11/2004
4	Biomarkers (Surrogate Marker)IBA 10/2019 - 04/2003
4	Topotecan (Hycamtin)FDA LinkGeneric 10/2019 - 10/2008
4	Carboplatin (JM8)FDA LinkGeneric 08/2017 - 01/2002
4	Adenosine Triphosphate (ATP)IBA 01/2014 - 08/2011
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2012 - 01/2002
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2009 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2011
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 10/2008
3	MicroRNAs (MicroRNA)IBA 10/2016 - 07/2012
3	Immunoglobulin FragmentsIBA 01/2015 - 10/2011
3	AntibodiesIBA 09/2012 - 05/2006
3	Genz-644282IBA 02/2012 - 05/2011
3	Angiogenesis InhibitorsIBA 11/2011 - 02/2005
3	erucylphosphocholineIBA 08/2008 - 09/2003
3	CytokinesIBA 08/2006 - 10/2002
2	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2007
2	AntigensIBA 11/2021 - 04/2008
2	Temozolomide (Temodar)FDA LinkGeneric 10/2021 - 01/2017
2	Gemcitabine FDA Link 10/2019 - 10/2002
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2018 - 01/2017
2	Monoclonal AntibodiesIBA 01/2016 - 03/2009
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2016 - 08/2004
2	Bortezomib (Velcade)FDA Link 07/2015 - 03/2015
2	Proteasome InhibitorsIBA 07/2015 - 03/2015
2	Biological ProductsIBA 11/2014 - 01/2010
2	EnzymesIBA 09/2013 - 10/2012
2	TubulinIBA 09/2012 - 10/2009
2	CamptothecinIBA 05/2011 - 10/2008
2	topovaleIBA 05/2011 - 10/2008
2	Docetaxel (Taxotere)FDA Link 05/2011 - 10/2009
2	Topoisomerase I InhibitorsIBA 05/2011 - 10/2008
2	Small Interfering RNA (siRNA)IBA 03/2011 - 01/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2011 - 01/2009
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2008 - 11/2003
2	matrigelIBA 10/2003 - 09/2003
2	CollagenIBA 10/2003 - 09/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2003 - 10/2002
2	Protein Kinases (Protein Kinase)IBA 10/2002 - 08/2002
2	317615 x 2HClIBA 08/2002 - 01/2002
1	trastuzumab deruxtecanIBA 01/2022
1	SuspensionsIBA 12/2021
1	Lysine (L-Lysine)FDA Link 11/2021
1	Histones (Histone)IBA 11/2021
1	7-aminoactinomycin DIBA 01/2021
1	birinapantIBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	CytidineIBA 01/2021
1	adavosertibIBA 01/2020
1	Aurora KinasesIBA 01/2020
1	exodeoxyribonuclease IIBA 01/2020
1	VTP50469IBA 12/2019
1	ChromatinIBA 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019
1	Cisplatin (Platino)FDA LinkGeneric 10/2019
1	ProdrugsIBA 01/2019
1	prexasertibIBA 01/2019

Therapy/Procedure

33	Therapeutics 01/2022 - 01/2002
7	Drug Therapy (Chemotherapy) 01/2021 - 10/2002
3	Radiotherapy 10/2018 - 08/2002
1	Precision Medicine 12/2021